[HTML][HTML] Microbial resistance movements: an overview of global public health threats posed by antimicrobial resistance, and how best to counter
Antibiotics changed medical practice by significantly decreasing the morbidity and mortality
associated with bacterial infection. However, infectious diseases remain the leading cause …
associated with bacterial infection. However, infectious diseases remain the leading cause …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
JS Smolen, R Landewé, J Bijlsma… - Annals of the …, 2017 - ard.bmj.com
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international …
Against Rheumatism (EULAR) RA management recommendations. A large international …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
JS Smolen, RBM Landewé, JWJ Bijlsma… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …
rheumatoid arthritis (RA) management recommendations to account for the most recent …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
JS Smolen, RBM Landewé, SA Bergstra… - Annals of the …, 2023 - ard.bmj.com
Objectives To provide an update of the EULAR rheumatoid arthritis (RA) management
recommendations addressing the most recent developments in the field. Methods An …
recommendations addressing the most recent developments in the field. Methods An …
[图书][B] The evolving threat of antimicrobial resistance: options for action
World Health Organization - 2012 - apps.who.int
国家の医療費に余裕がない大幅な財政負担に加えて, 抗菌薬耐性は耐性菌感染の国境を越えた
国際的な移動や貿易に悪い影響となるように, 医療部門を超えて経済的影響を持ちつつあります …
国際的な移動や貿易に悪い影響となるように, 医療部門を超えて経済的影響を持ちつつあります …
Performance of retail pharmacies in low-and middle-income Asian settings: a systematic review
In low-and middle-income countries (LMIC) in Asia, pharmacies are often patients' first point
of contact with the health care system and their preferred channel for purchasing medicines …
of contact with the health care system and their preferred channel for purchasing medicines …
[PDF][PDF] Applying COM-B to medication adherence: a suggested framework for research and interventions
C Jackson, ÂL Eliasson, N Barber… - European Health …, 2014 - ehps.net
On average only fifty percent of people with long term conditions are adherent to their
treatment across diverse disease and patient groups (Holloway & van Dijk, 2011; Sabaté …
treatment across diverse disease and patient groups (Holloway & van Dijk, 2011; Sabaté …
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews
Background Many systematic reviews exist on interventions to improve safe and effective
medicines use by consumers, but research is distributed across diseases, populations and …
medicines use by consumers, but research is distributed across diseases, populations and …
[HTML][HTML] Global research publications on irrational use of antimicrobials: call for more research to contain antimicrobial resistance
WM Sweileh - Globalization and Health, 2021 - Springer
Background Irrational use of antimicrobials is highly prevalent. It is a major driving factor for
antimicrobial resistance (AMR). Research on irrational antimicrobial use is important for …
antimicrobial resistance (AMR). Research on irrational antimicrobial use is important for …
Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE …
Background To date, head-to-head trials comparing the efficacy and safety of biological
disease-modifying antirheumatic drugs within the same class, including TNF inhibitors, in …
disease-modifying antirheumatic drugs within the same class, including TNF inhibitors, in …